Among the 23 RPs showing a decreased ratio in cancer, heterozygous deletion of RPL22 is observed in approximately 10% of T-acute lymphoblastic leukemia (T-ALL) cases (Rao et al., 2012). This evidence concerns the gene RPL22 and cancer.